Single-Cell Sequencing Startup Mission Bio Raises $30 Million

Mission Bio has raised $30 million Series B from investors such as Mayfield, Agilent Technologies and LabCorp.

Source: Forbes.com Healthcare News - December 13, 2018 Category: Pharmaceuticals Authors: Michela Tindera, Forbes Staff Source Type: news